SOVENTUS DX12 (Chlorpheniramine Maleate (4mg/5ml) + Dextromethorphan Hydrobromide (30mg/5ml))

Soventus DX 12 Sustained Release Oral Suspension is a formulation that combines two active ingredients designed to address the symptoms associated with dry cough. This medication offers short-term relief from cough triggered by throat irritation, sneezing, and a runny nose. The mechanism of action involves inhibiting the cough reflex in the brain and counteracting the impact of histamine, which is responsible for allergic responses. Administration of Soventus DX 12 can occur with or without food, with the specific dosage and duration being determined by a healthcare professional based on individual health needs and response to treatment. It is crucial to adhere to the prescribed treatment regimen as stopping the medication prematurely may lead to a resurgence of symptoms and potential worsening of the condition. Patients are encouraged to inform their healthcare provider of all other medications they are currently taking, as there may be interactions that could alter the effectiveness of this treatment. Staying well-hydrated while using this medication is recommended. Additionally, individuals with liver conditions should disclose this to their doctor to ensure appropriate dosing is provided. Pregnant or nursing individuals should also seek medical advice prior to initiating treatment with this suspension. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.